Earnings Beat Triggers Selloff: Astera Labs delivered impressive Q4 results, with revenue of $271 million surpassing estimates of $250 million and EPS of $0.58 topping forecasts of $0.52. Despite the strong performance fueled by AI connectivity demand, the stock plunged around 10% in after-hours trading as investors grappled with lofty valuations.
Margin Concerns Emerge: Discussions highlight worries over anticipated gross margin compression from higher-mix Taurus modules and a new $6.5 billion Amazon warrant deal. Q1 guidance for $292 million in revenue beat consensus but failed to ignite enthusiasm amid the stock's recent run-up. Traders view the reaction as an overreaction, with the AI infrastructure story remaining robust.
Long-Term Optimism Persists: Social media buzz underscores Astera Labs' explosive growth, with 92% year-over-year revenue surge and expanding hyperscaler partnerships. While short-term volatility reigns, many see the dip as a buying opportunity in this key AI enabler.
Note: This discussion summary was generated from an AI condensation of post data.
Astera Labs Insider Trading Activity
Astera Labs insiders have traded $ALAB stock on the open market 129 times in the past 6 months. Of those trades, 0 have been purchases and 129 have been sales.
Here’s a breakdown of recent trading of $ALAB stock by insiders over the last 6 months:
- MANUEL ALBA has made 0 purchases and 64 sales selling 366,000 shares for an estimated $62,118,915.
- JITENDRA MOHAN (Chief Executive Officer) has made 0 purchases and 7 sales selling 181,900 shares for an estimated $29,869,287.
- SANJAY GAJENDRA (President and COO) has made 0 purchases and 7 sales selling 181,900 shares for an estimated $29,869,287.
- PHILIP MAZZARA (General Counsel and Secretary) has made 0 purchases and 31 sales selling 41,857 shares for an estimated $7,589,140.
- MICHAEL TRUETT TATE (Chief Financial Officer) has made 0 purchases and 6 sales selling 30,291 shares for an estimated $5,115,043.
- JACK R LAZAR has made 0 purchases and 14 sales selling 25,000 shares for an estimated $4,388,271.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Astera Labs Revenue
Astera Labs had revenues of $270.6M in Q4 2025. This is an increase of 91.77% from the same period in the prior year.
You can track ALAB financials on Quiver Quantitative's ALAB stock page.
Astera Labs Hedge Fund Activity
We have seen 412 institutional investors add shares of Astera Labs stock to their portfolio, and 317 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 4,105,012 shares (+57.6%) to their portfolio in Q3 2025, for an estimated $803,761,349
- ALLIANCEBERNSTEIN L.P. removed 3,472,895 shares (-54.3%) from their portfolio in Q3 2025, for an estimated $679,992,841
- BARCLAYS PLC added 1,961,995 shares (+3711.6%) to their portfolio in Q3 2025, for an estimated $384,158,621
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,507,675 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $250,816,813
- AMUNDI added 1,319,643 shares (+1298.6%) to their portfolio in Q3 2025, for an estimated $258,386,099
- BANK OF AMERICA CORP /DE/ added 1,182,739 shares (+148.1%) to their portfolio in Q3 2025, for an estimated $231,580,296
- RAFFERTY ASSET MANAGEMENT, LLC added 1,070,475 shares (+inf%) to their portfolio in Q3 2025, for an estimated $209,599,005
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Astera Labs Analyst Ratings
Wall Street analysts have issued reports on $ALAB in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 01/15/2026
- BNP Paribas Exane issued a "Outperform" rating on 11/20/2025
- Northland Capital Markets issued a "Outperform" rating on 11/17/2025
- Stifel issued a "Buy" rating on 11/05/2025
- JP Morgan issued a "Overweight" rating on 11/05/2025
- Deutsche Bank issued a "Buy" rating on 09/02/2025
- CICC issued a "Outperform" rating on 08/29/2025
To track analyst ratings and price targets for Astera Labs, check out Quiver Quantitative's $ALAB forecast page.
Astera Labs Price Targets
Multiple analysts have issued price targets for $ALAB recently. We have seen 13 analysts offer price targets for $ALAB in the last 6 months, with a median target of $210.0.
Here are some recent targets:
- Atif Malik from Citigroup set a target price of $250.0 on 02/11/2026
- Srini Pajjuri from RBC Capital set a target price of $225.0 on 01/15/2026
- Gus Richard from Northland Capital Markets set a target price of $195.0 on 12/09/2025
- Karl Ackerman from BNP Paribas Exane set a target price of $225.0 on 11/20/2025
- Harlan Sur from JP Morgan set a target price of $215.0 on 11/05/2025
- Suji Desilva from Roth Capital set a target price of $225.0 on 11/05/2025
- Joseph Moore from Morgan Stanley set a target price of $210.0 on 11/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
